Main Menu
Meet us at ISPOR EU 2025 Glasgow at booth #619
Know More

Advancing HEOR by Connecting Classic to Innovation

ConnectHEOR is the new-age services and technology leader connecting the precision of responsible AI and the deep domain expertise on HEOR, RWE and Access to build intelligent evidence that accelerates transformative healthcare decisions.
Contact us
Explore Our AI solutions

Explore Our Services

At ConnectHEOR, we Connect and nurture the brightest global minds, providing a platform for them to thrive. Our world-class team, contributors to HTA bodies such as NICE, leaders within ISPOR, Royal Society-recognised experts, and award-winning consultants – bring depth, precision, and creativity to every collaboration. They work with you to transform evidence into strategies that create meaningful and lasting impact in healthcare.

Artificial Intelligence

9+ AI Accelerators/Agents, 100+ POCs and a highly skilled team of data engineers and AI experts

Know More

Health Economic Modelling

Cutting edge statistical methods to ensure scientifically robust and user-friendly models

Know More

Patient Centric Research

Actively involving patients throughout the research for holistic and shared healthcare decision-making

Know More

Review & Evidence Synthesis

Innovative Indirect Treatment Comparisons (ITCs), Single-Arm Studies, Literature Reviews

Know More

RWE & Healthcare Analytics

Analysis of Real-World Data to study disease epidemiology and its impact in each phase of product lifecycle

Know More

Market Access & Value Communication

Effectively communicating the clinical and economic value of healthcare technologies to payers

Know More

What Our Customers Say

“What they promise, they deliver - and often go beyond. From proposal to delivery, ConnectHEOR is one of the most reliable, non-fussy, and collaborative teams. Leadership remains hands-on, ensuring scientific excellence at every stage.”
Senior DirectorGlobal Market Access, Top 10 Pharma
“ConnectHEOR delivered an exceptional rare disease HTA submission - scientifically robust, methodologically sound, and delivered on time. A team you can trust fully.”
DirectorHEOR Global Pharma
“Brilliant experience working on our oncology diagnostic model. ConnectHEOR combined technical precision with real-world understanding — a rare blend of science and pragmatism.”
Vice PresidentMarket Access, Diagnostics Manufacturer
“ConnectHEOR supported our AI-enabled product value strategy with deep technical insight and clarity. Their ability to simplify complex analytics into actionable evidence is impressive.”
Head of Digital Health & InnovationHealthtech company
“Outstanding flexibility and scientific rigour - ConnectHEOR guided our medical device HTA with clarity and confidence. Seamless collaboration from start to finish.”
Executive Director​Global HEOR & Access, Pharma Company​
“They are not just problem solvers — they are problem identifiers. ConnectHEOR challenges thinking even at the RFP stage, helping us reshape our project approach for greater scientific and strategic value. That early insight sets them apart.”
Vice PresidentGlobal Market Access, Pharma Company​

“What they promise, they deliver – and often go beyond. From proposal to delivery, ConnectHEOR is one of the most reliable, non-fussy, and collaborative teams. Leadership remains hands-on, ensuring scientific excellence at every stage.”

Senior Director

Global Market Access, Top 10 Pharma

“ConnectHEOR delivered an exceptional rare disease HTA submission – scientifically robust, methodologically sound, and delivered on time. A team you can trust fully.”

Director

HEOR, Global Pharma

“Brilliant experience working on our oncology diagnostic model. ConnectHEOR combined technical precision with real-world understanding — a rare blend of science and pragmatism.”

Vice President

Market Access, Diagnostic Manufacturer 

“ConnectHEOR supported our AI-enabled product value strategy with deep technical insight and clarity. Their ability to simplify complex analytics into actionable evidence is impressive.”

Head of Digital Health & Innovation

HealthTech Company

“Outstanding flexibility and scientific rigour – ConnectHEOR guided our medical device HTA with clarity and confidence. Seamless collaboration from start to finish.”

Global Market Access Lead

MedTech Company

“They are not just problem solvers — they are problem identifiers. ConnectHEOR challenges thinking even at the RFP stage, helping us reshape our project approach for greater scientific and strategic value. That early insight sets them apart.”

Executive Director

Global HEOR & Access, Pharma Company

What our people say

“I was highly impressed with the end-to-end senior staff support, technical knowledge, timeliness and the quality of ConnectHEQR’s work…

Devian Parra

Consultant

Read More

Working at ConnectHEOR feels like being part of a big, brainy & diverse family where your ideas truly matter…

Anuja Bhardwaj

Senior Analyst

Read More

The ConnectHEOR team truly lives its motto — “Kindness is cost-effective.” We consistently deliver high-quality work that makes a real difference…

Eleni Tente

Consultant

Read More

Working at ConnectHEOR has been a wonderful journey of learning, growth, and excellence. Apart from collaborating with the brightest minds…

Hanan Irfan

Senior Analyst

Read More

Working at ConnectHEOR has been an inspiring journey – a space where creativity thrives, continuous learning is the norm, and collaboration…

Syed Salleh

Consultant

Read More

Our Latest Publications

View All

TECHNICAL SUPORT DOCUMENT 26: Expert Elicitation for Long-term survival Outcomes

Jeremy E Oakley, Shijie Ren, Jessica E. Forsyth, John Paul Gosling, Kevin Wilson, Nick Latimer, Mark J. Rutherford, Lesley Uttley, James Fotheringham
Advancing unanchored simulated treatment comparisons: a novel implementation and simulation study
Shijie Ren, Sa Ren, Nicky J. Welton, Mark Strong
Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden
Srivastava T, Prabhu V, Li H, Xu R, Zarabi N, Zhong Y, Pellissier J, Perini R, Ronald de Wit, Mamtani R
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review
Tobias Sydendal Grand, Shijie Ren, James Hall, Daniel Oudin Åström, Stephane Regnier, Praveen Thokala
Scientific Publications
0 +
Countries
0 +
Therapeutic Areas
0 +
Successful HEOR & RWE Projects
0 +

Our Latest  Blog & Webinar

View All

Indirect Treatment Comparisons (ITCs) are pivotal in evidence generation but with multiple approaches available, how do you choose the right one?

In our recent Webinar, Prof Kate Ren and Dr Hugo P. talking about practical roadmap on:

  • MAIC, STC, and ML-NMR – understanding the strengths, limitations, and best-fit scenarios
  • Key decision factors when selecting your method
  • Practical tips to ensure methodological rigour and defensibility
To watch the webinar register
Empowering Health technology assessments through Population-adjusted indirect comparisons
Read More
Use of Artificial Intelligence in Systematic Literature Review
Read More
From Compassion to Cure: Caregiver’s Quality of Life as a Treatment Success Yardstick in Clinical Trials
Read More
Champions of Healthcare: Why Community Health Workers Deserve More Recognition
Read More

Our Presence on the World Stage

ISPOR

ConnectHEOR has been proudly exhibiting and presenting at ISPOR for several years, showcasing world-class…

Read More

EPA

We were proud to represent ConnectHEOR at Evidence 360: RWE, Pricing & Reimbursement Summit Europe…

Read More

NHTA

Our South Asia team was proud to be represented at the National Health Technology Assessment (NHTA) Confere…

Read More

Connect with us

“I was highly impressed with the end-to-end senior staff support, technical knowledge, timeliness and the quality of ConnectHEQR’s work. Provided cost….

Devian Parra

Consultant

Working at ConnectHEOR feels like being part of a big, brainy & diverse family where your ideas truly matter. Every day brings fresh challenges—and just the right dose of mentorship, support, and caffeine to keep it all fun and functional!

Anuja Bhardwaj

Senior Analyst

The ConnectHEOR team truly lives its motto — “Kindness is cost-effective.” We consistently deliver high-quality work that makes a real difference. I’m excited for the future and the continued opportunity to develop my skills here.

Eleni Tente

Consultant

Working at ConnectHEOR has been a wonderful journey of learning, growth, and excellence. Apart from collaborating with the brightest minds in the industry, ConnectHEOR also offers a warm, supportive environment for new joiners to flourish.

Hanan Irfan

Senior Analyst

Working at ConnectHEOR has been an inspiring journey – a space where creativity thrives, continuous learning is the norm, and collaboration with experts from diverse backgrounds drives meaningful growth across the company

Syed Salleh

Consultant

For ISPOR

ConnectHEOR has been proudly exhibiting and presenting at ISPOR for several years, showcasing world-class research across posters, theater presentations, and symposia. Through these platforms, the team continues to share innovative insights and thought leadership that shape global health economics and outcomes research.

For EPA

We were proud to represent ConnectHEOR at Evidence 360: RWE, Pricing & Reimbursement Summit Europe 2025 in Frankfurt! Our own Shilpi Swami, VP Consulting & Strategy, took the stage as both featured speaker and panel moderator.

For NHTA

Our South Asia team was proud to be represented at the National Health Technology Assessment (NHTA) Conference 2025, held from July 29–31 in Malaysia. They actively participated in insightful discussions on the future of health technology and the importance of evidence-based, equitable healthcare across the region.

Judit Banhazi

Specialty
Value and Access

Role
Vice President

Degree
MD Medicine, JD Law

Judit Banhazi

MD Medicine, JD Law

Judit Banhazi, based in Basel, Switzerland, brings over 20 years of experience in HEOR, Market Access, and Health Policy.
She has led HEOR strategies in hematology and initiated EU HTA policy activities. Judit began her career as a physician and has worked at prime global pharma companies. Her academic prowess is excellent with a peculiar combination of an MD in Medicine and a JD in Law, she has been at forefront of health economics by being involved in HTA policy discussions with EFPIA and HTAi.
Known for her collaborative spirit and practical approach, Judit is passionate about learning and delivering quality work. Outside of work, she enjoys spending time with family and friends, travelling, and running.

Adam Ball

Specialty
Business Development Manager

 

Adam Ball

Business Manager

I am delighted to be part of the team here at ConnectHEOR. To tell you a bit about me, I have 10 years experience within Talent Acquisition within HEOR, RWE and Market Access. I have built a global network during this time and am excited to utilize this to help us grow as business. 

 

Outside of work I love sports, playing football and squash regularly, as well as going to the gym. I also enjoy watching sports mainly football and tennis. I have a new born daughter too so she is taking up a lot of my time and is a bundle of joy. I also play drums and like to think I have a broad taste in Music.

 

Eleni Tente

Specialty
Medical writing, Evidence planning

Role
Consultant, Medical writer

Degree
PhD – Molecular biology and genetics

Eleni Tente

PhD – Molecular biology and genetics

Eleni Tente is an experienced medical writer with proven ability to translate complex scientific information into clear, concise, and impactful content to diverse audiences. She has a strong background in integrated evidence planning, publications, internal communications and e-learning development, complemented by an understanding of various therapeutic areas.

Eleni holds a PhD in molecular biology and genetics from the University of Cambridge and an MSc in plant genetic manipulation from the University of Nottingham.

In her free time, Eleni enjoys diving into a good book, fishing along the coast, or planning her next thrilling scuba diving adventure to swim with sharks.

Syed Salleh

Specialty
HTA Modelling and Discrete-event Simulation

Role
Consultant, Modeling & Analytics

Degree
PhD – Health & Related Research

Syed Salleh

PhD. Health & Related Research

Syed Salleh brings extensive experience in HTA modeling, having successfully led the development of both de novo and adaptation models for HTA listings across multiple countries, including Malaysia, Philippines, and the UK. His work spans key therapeutic franchises such as oncology, cardiometabolic, and respiratory. Syed has also delivered critical insights to healthcare professionals through MYSPOR, ITTP, and IKN virtual CME events and numerous publications.

He holds a PhD in Health and Related Research from the School of Health and Related Research (ScHARR) at the University of Sheffield, UK, with a specialization in HTA and operational research, specifically in discrete-event simulation (DES) technique.

During his time in a leading pharmaceutical company, Syed played a key role in securing the listing of several key products in the Malaysia Ministry of Health Formulary and served as the primary contact for DES-related projects.

Besides work, Syed enjoys traveling, listening to music, and spending quality time with his family.

Thai-Son Tong

Specialty
Model Conceptualization and Data Analytics

Role
Senior Consultant

Degree
PhD – Health Economics

Thai-Son Tong

PhD. Health Economics

Thaison Tong has extensive work experience in health economics, decision modelling and big data analysis. He has a unique mix of experience in HEOR and RWE related research in academia and pharmaceutical industry. His expertise lies in health technology assessments (HTA), health economic modelling, simulation modelling, big data analytics and decision analysis. He has hands-on experience in a range of software and programming languages including R, R Shiny, R Markdown, Python, MS Excel, VBA, and Simul8. He has substantial experience of the health care system in the UK and other European countries.

Thaison has direct experience in building cost-effectiveness models from scratch and conducting big data analysis in several disease areas including dementia, vascular disease, and cancer.

Thaison’s PhD focus was to develop a de novo patient level model for the evaluation of different cognitive screening tests for early detection of dementia and mild cognitive impairment in primary care. He also looked at different methods for conducting economic evaluation in health care taking a broader/societal perspective. In addition, he investigated the use of Multiple Criteria Decision Analysis (MCDA) for economic evaluation.

Thaison also holds Academic Researcher position in School of Health and Related Research (ScHARR), University of Sheffield, UK and Honorary Researcher position in University of Bristol, UK.

Thaison’s likes to meditate, and play badminton, basketball and tennis.

Shilpi Swami

Specialty
Consulting and strategy

Role
Vice President

Degree
MSc. International Economics

Shilpi Swami

MSc. International Economics

Shilpi Swami is an internationally recognized leader in consulting, named among the World’s Top 25 Women Leaders in Consulting 2025 – a distinction that spans the entire consulting industry. She also serves as Chair-Elect of the ISPOR Oncology Special Interest Group and is a frequent speaker at leading scientific and policy forums, where she brings clarity and authority to complex healthcare access challenges.

As Vice President of Consulting and Strategy at ConnectHEOR, Shilpi provides both scientific and strategic leadership, guiding evidence generation and market access initiatives across Europe, North America, Latin America, Asia, and Australia. She has led numerous high-stakes HTA submissions and access strategies, combining methodological rigor with practical solutions that resonate with regulators, payers, and biopharma stakeholders.

Her multidimensional career – spanning academia, consulting, and biopharma equips her with a rare ability to bridge perspectives across research, policy, and industry. Previously a Research Fellow at the University of York, she contributed to advancing best practices in public health and health economics.

Shilpi is widely respected not only for her expertise but also for her people-first approach. She embodies the belief that Kindness is Cost-Effective™, demonstrating that strength in leadership comes from pairing scientific excellence with empathy, collaboration, and impact.

Hugo Pedder

Specialty Statistical Analysis and Evidence Synthesis

Role Senior Consultant

Degree PhD – Statistical Modelling

Hugo Pedder

PhD – Statistical Modelling

Hugo brings in a wealth of experience to ConnectHEOR from his extensive work in academia, focusing primarily on evidence synthesis and meta-analysis. Hugo holds PhD in Statistical Modelling from University of Briston and MSc in Medical Statistics from the London School of Hygiene and Tropical Medicine, and his background in neuroscience remains a passionate interest. Alongside working with ConnectHEOR, Hugo continues to part of NICE committee. His expertise includes advanced indirect treatment comparisons technique and has extensive experience of working with the NICE in UK. 

Beyond professional endeavors, Hugo is an enthusiastic outdoor adventurer, particularly enjoying mountain activities, climbing and ski mountaineering. From building rafts to exploring rivers in north of Sweden, he has lived an adventurous life outside of work and plans to continue to do so.

Kunal Hriday

Specialty
AI Strategy

Role
Director

Degree
MSc. Quantitative Economics

Kunal Hriday

MSc. Quantitative Economics

Kunal Hriday is a business strategy and data science professional with experience in helping organizations crack through notorious business challenges. Kunal is proficient building scalable AI products, specialized Intelligence, automations, business analytics, product lifecycle management and business development. Working as a Data science professional he has spent time in problem solving across variety of industries including Banking, logistics and Health and is now fully dedicated to HEOR. Kunal has hands on experience in various statistical programming tools and languages.

He also holds a masters’ in Quantitative Economics from Indian Statistical Institute and a bachelors’ degree in Business Economics. Excellent in business communication, he is passionate about studying environmental economics and related theories of welfare optimization.

Kunal is trained in Indian Classical Music and finds solace in music when not at work.

Raju Gautam

Specialty
Evidence Review

Role
Principal Consultant

Degree
PhD (Pharmacy)

Raju Gautam

PhD Pharmacy

Raju Gautam spearheads evidence review at ConnectHEOR and  has extensive work experience in evidence review and synthesis, value communications, scientific publications, medical writing and project management.
His expertise lies in systematic and targeted literature reviews, meta-analyses, network meta-analyses, value communications (AMCP and Global Value Dossiers), RWE study design and publications (manuscripts, posters, and abstracts).
He has experience working in Global pharma companies, consulting and CRO environment for several therapy areas including Cardiovascular, Oncology, Neurology, Respiratory, Ophthalmic, Rare Diseases, and Vaccines. He has more than 40 publications in international journals as an author.
Raju also likes jogging, yoga and meditation.

Radha Sharma

Specialty:
Patient preference research, survey, In-depth interviews, COA, Evidence review and conceptualisation of study

Role:
Director – Patient-Centered Outcomes Research

Degree:
MBBS (Bachelor of Medicine and Bachelor of Surgery), PhD (Global Public Health) – University of York

Radha Sharma

PhD (Global Public Health)

Radha Sharma spearheads Patient-Centered Outcomes Research at ConnectHEOR. She has a background in medicine, public health, and epidemiology.

Her expertise includes global health research, preference elicitation, mixed-method studies, consensus workshops, qualitative health research, epidemiological analysis of big data sets, RWE study design, scientific writing, and literature reviews. Her primary focus is integrating patient perspectives into all stages of health technology assessment (HTA) and healthcare decision-making processes.

Her extensive expertise in mixed-method studies and active patient/stakeholder engagement ensures that her research is methodologically rigorous and patient-centric. Radha is an avid hiker and enjoys exploring the beautiful Canadian Rockies.

Kate Ren

Specialty
Statistical Analysis and Evidence Synthesis

Role
Director of Statistics

Degree
Ph.D Probability and Statistics

Kate Ren

PhD Probability and Statistics

Kate spearheads Statistics and Evidence Synthesis at ConnectHEOR. She has more than 10 years of experience in conducting statistical analysis in HTA. Kate has PhD in Probability and Statistics specialising in Bayesian methods in clinical trial design.

She specializes in Bayesian methods in health economics and the elicitation of experts’ beliefs and has extensive experience of conducting evidence synthesis, including, meta-analysis, network meta-analysis, MAIC, STC, ML-NMR etc. Besides working with ConnectHEOR, she is also a part of NICE Committee and University of Sheffield.

Tushar Srivastava

Specialty
Decision Modelling and AI Initiatives

Role
Director

Degree
MSc – Statistics and Computing

Tushar Srivastava

MSc – Statistics and Computing

Tushar Srivastava is a health economics and outcomes research (HEOR) leader whose journey spans academia, consulting, and the life sciences industry – bringing a rare breadth of perspective to evidence generation. Endorsed as a Global Talent by the Royal Society, UK, and holding an MSc in Statistics and Computing, he has authored numerous publications in modeling, indirect treatment comparisons, patient-centered outcomes research, evidence reviews, and AI.

He has built a reputation for uniting scientific excellence with technological innovation. From developing decision models himself to shaping and mentoring world-class modeling teams, Tushar has consistently advanced the science and practice of HEOR with a forward-looking, technology-driven vision.

At ConnectHEOR, Tushar directs HEOR activities and leads the integration of responsible AI into evidence generation. His vision is transforming the field from a human-only framework to an intelligent, interactive, and scalable hybrid intelligence framework – where human expertise works in synergy with AI.

Working diligently to improve patient lives through research and technology, he brings scientific rigor and technological foresight to projects across diverse therapy areas and health technologies, including pharmaceuticals, medical devices, diagnostics, digital health, and public health programs. His work is widely published and presented internationally, reflecting both methodological depth and innovative thinking.

He believes that Kindness is Cost-Effective™ and continues to ensure that ConnectHEOR’s science and technology are always guided by a human-centered ethos.